<img src="https://trc.taboola.com/1321591/log/3/unip?en=page_view" width="0" height="0" style="display:none">
Fact Check Library

Fact Check with Logically.

Download the Free App Today

true
true

CLAIM ID

abf4056a

The guest rooms at the Vinayaka temple located in Kanipakam in Andhra Pradesh’s Chittoor district has been converted into a coronavirus quarantine centre.

The Executive Officer of the Kanipakam temple has said that the guest house at the Vinayaka temple is used as a quarantine centre due to COVID-19.

The Executive Officer of the Kanipakam temple has said that the guest house at the Vinayaka temple is used as a quarantine centre due to COVID-19.The News Minute exclusive article dated 7 April 2020 states that Executive Officer of the Kanipakam temple Devullu confirmed that the Varasiddhi Vinayaka temple administration had converted the 100-room guest house into a quarantine facility due to COVID-19.

A Deccan Herald news article has reported that part of the Kanipakam Varasiddhi Vinayaka Temple at Kanipakam in Chittoor, Andhra Pradesh had been turned into a quarantine centre to mitigate the spread of the coronavirus.

The Telugu360 news article states that BJP state president Kanna Laxminarayana sent a letter to Andhra Pradesh Chief Minister YS Jagan Mohan Reddy objecting the state government’s decision to use the Vinayaka temple premises in Kanipakam as a COVID-19 quarantine centre.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.

Have a question or correction on one of our fact-checks?

If you think a claim has been misjudged or requires correction, please send us evidence to support your error claim. We will revisit our evidence and verdict and conduct additional research to verify new information.

Fact Check of the Day

misleading

397 children were diagnosed with heart inflammation after receiving Pfizer’s COVID-19 vaccine in U.S.